PRMB

PRMB Other Income/Expenses (Net)

-$359.90MTTM · USD

Period ending:

PRMB FY Other Income/Expenses (Net)USD
PRMB FY Other Income/Expenses (Net)1992-01-31: -$2.80M1993-01-31: -$2.30M1994-01-31: -$1.80M1995-01-31: -$3.50M1996-01-31: -$39.90M1997-01-31: -$26.20M1998-01-31: -$45.10M1998-12-31: -$108.00M1999-12-31: -$27.40M2000-12-31: -$26.60M2001-12-31: -$30.20M2002-12-31: -$34.90M2003-12-31: -$31.20M2004-12-31: -$29.90M2005-12-31: -$67.10M2006-12-31: -$68.20M2007-12-31: -$119.10M2008-12-31: -$141.80M2009-12-31: -$39.70M2010-12-31: -$21.30M2011-12-31: -$68.10M2012-12-31: -$55.20M2013-12-31: -$69.70M2014-12-31: -$106.00M2015-12-31: -$130.50M2016-12-31: -$76.60M2017-12-31: -$116.80M2018-12-31: -$65.60M2019-12-31: -$113.30M2020-12-31: -$280.50M2021-12-31: -$119.20M2022-12-31: -$57.20M2023-12-31: -$305.00M2024-12-31: -$543.70M2025-12-31: -$606.50M$0.00-$606.50M
1992-01-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

PRMB other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 35 observations from Jan 31, 1992 to Dec 31, 2025.

Primo Brands Corporation Class A Common Stock Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
-606,500,000
-543,700,000
-305,000,000
-57,200,000
-119,200,000
-280,500,000
-113,300,000
-65,600,000
-116,800,000
-76,600,000
-130,500,000
-106,000,000
-69,700,000
-55,200,000
-68,100,000
-21,300,000
-39,700,000
-141,800,000
-119,100,000
-68,200,000
-67,100,000
-29,900,000
-31,200,000
-34,900,000
-30,200,000
-26,600,000
-27,400,000
-108,000,000
-45,100,000
-26,200,000
-39,900,000
-3,500,000
-1,800,000
-2,300,000
-2,800,000

Compare other income/expenses (net)

All PRMB financial metrics · PRMB stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.